Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 565-567

  Carella, Angelo M ^a,c   Lerma, Enrica ^a   Corsetti, Maria T ^a   Dejana, Anna ^a   Celesti, Lidia ^a   Casarino, Lucia ^b   De Stefano, Francesco ^b   Frassoni, Francesco ^a  

^a Azienda Ospedaliera   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Hematology and ABMT Unit   (Italy)

Author keywords

Allografting; Cytogenetic remission; Immunosuppressive therapy; Molecular remission

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE;

ADULT; ALLOGRAFT; ARTICLE; CANCER REGRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HLA MATCHING; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT;

ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; TRANSPLANTATION CONDITIONING;

EID: 0031723944     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01057.x     Document Type: Article

References (4)

1. Carella, A.M., Lerma, E., Celesti, L., Dejana, A., Zikos, P., Corsetti, M.T. & Frassoni, F. (1998) Effective mobilization of Philadelphia-chromosome negative cells in chronic myelogenous leukaemia patients using a less intensive regimen. British Journal of Haematology, 100, 445-448.
2. Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Körbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy. Blood, 89, 4531-4536.
3. Khouri, I., Keating, M.J., Przepiorka, D., O'Brien, S., Giralt, S., Körbling, M. & Champlin, R. (1996) Engraftment and induction of GvL with fludarabine (FAMP)-based non-ablative preparative regimen in patients with chronic lymphocytic leukemia (CLL) and lymphoma. Blood, 88, 301a (abst. 1194).
4. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756-763.